Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Videos
Patient Care
Patient Monitoring
Return to: MDBR Home | Patient Care | Patient Monitoring | News
Search Refinements

Patient Monitoring News

View news from other Medical Devices sectors:
61-75 of 875 results
Medtronic begins study to evaluate optimized spinal cord stimulation programming
By MDBR Staff Writer
Medtronic has enrolled first patient in pain study to evaluate optimized spinal cord stimulation (SCS) programming.
Patient Care > Patient Monitoring > News
Miracor Medical raises € 25m to develop PiCSO impulse system
Miracor Medical Systems (Miracor Austria) and Miracor Medical have closed €25m as part of a series D financing round.
Patient Care > Patient Monitoring > News
Masimo gets CE mark for Oxygen Reserve Index rainbow Lite sensors
Masimo has secured CE mark for RD rainbow Lite SET sensors, which enable the monitoring of Masimo Oxygen Reserve Index (ORi) and RPVi.
Patient Care > Patient Monitoring > News
French firm Biocorp gets CE mark for Easylog smart cap
By MDBR Staff Writer
Biocorp, a developer of medical devices and smart-drug delivery systems, has secured CE mark approval for its Easylog smart cap.
Patient Care > Patient Monitoring > News
Glaukos to begin randomized US IDE clinical trial for iStent SA system
Glaukos announced that the US Food and Drug Administration (FDA) is allowing the company to move forward with a US investigational device exemption (IDE) pivotal study of its iStent SA trabecular micro-bypass system.
Patient Care > Patient Monitoring > News
Respicardia raises $58.5m to commercialize remede system for CSA treatment
By MDBR Staff Writer
Medical technology firm Respicardia has raised $58.5 financing to advance the commercialization of remedē system to treat central sleep apnea (CSA).
Patient Care > Patient Monitoring > News
Intersect ENT gets FDA approval for SINUVA sinus implant
Intersect ENT has received approval from the US Food and Drug Administration (FDA) for the SINUVA (mometasone furoate) Sinus Implant, a new targeted approach to treating recurrent nasal polyp disease in patients who have had previous ethmoid sinus surgery.
Patient Care > Patient Monitoring > News
FDA approves Boston Scientific's Vercise deep brain stimulation system
By MDBR Staff Writer
Boston Scientific has secured approval from the US Food and Drug Administration (FDA) for its Vercise deep brain stimulation (DBS) system.
Patient Care > Patient Monitoring > News
Stryker to buy US firm Entellus Medical for $662m
By MDBR Staff Writer
Stryker has signed an agreement to acquire US medical technology firm Entellus Medical for around $662m.
Patient Care > Patient Monitoring > News
LivaNova to buy remaining stake in ImThera Medical for $225m
By MDBR Staff Writer
UK-based medical technology firm LivaNova has agreed to purchase the remaining stake in US firm ImThera Medical for around $225m.
Patient Care > Patient Monitoring > News
Stimwave secures FDA 510(k) clearance for SandShark injectable anchoring system
Stimwave announced the SandShark Injectable Anchor System received the US Food and Drug Administration’s 510(k) clearance.
Patient Care > Patient Monitoring > News
FDA approves first study of Insightec’s Exablate Neuro to open blood-brain barrier in Glioblastoma patients
Insightec has received approval from the US Food and Drug Administration (FDA) to initiate a study to evaluate the safety and feasibility of the Exablate Neuro for disrupting the blood brain barrier (BBB) in patients with Glioblastoma.
Patient Care > Patient Monitoring > News
FDA approves first medical device system to adjust artificial lens after cataract surgery
By MDBR Staff Writer
RxSight has secured approval from the US Food and Drug Administration (FDA) for its light adjustable lens and light delivery device (LDD) to treat patients with pre-existing astigmatism of ≥ 0.75 diopters undergoing cataract surgery.
Patient Care > Patient Monitoring > News
Novocure’s trial shows increased compliance with Optune predicted enhanced survival in glioblastoma patients
Novocure has announced results from a retrospective post-hoc analysis of its phase 3 pivotal EF-14 trial data showing that increased compliance with Optune predicted increased survival in glioblastoma (GBM) patients.
Patient Care > Patient Monitoring > News
Cianna Medical gets FDA nod for wire-free radar breast tumor localization system
By MDBR Staff Writer
Cianna Medical has secured approval from the US Food and Drug Administration (FDA) for its wire-free radar breast tumor localization system.
Patient Care > Patient Monitoring > News
61-75 of 875 results